Related Experiment Videos
ABVD chemotherapy of Hodgkin's disease
Z Molnár1, T Schneider, E Várady
1National Institute of Oncology, Budapest, Hungary.
Neoplasma
|January 1, 1997
Abstract:
The authors report on their results in ABVD therapy, which was given by 91 patients with Hodgkin's disease as first-line treatment. 78 patients (85% achieved complete, 10 (11%) partial remission, 3 (4%) did not respond to therapy. In the follow-up period (36-223 months) 6 patients (7%) died because of the progression of Hodgkin's disease. Serious side effects or treatment-related death did not occur. Based on their results of ABVD, the authors find ABVD chemotherapy effective as first-line treatment of Hodgkin's disease.